Variable | eGFR <90 ml/min/1.73 m2 | OR (95% CI) | p-value |
---|---|---|---|
Median age (Q1;Q3)months | 77 (57;103) | 0.98 (0.97; 0.99) | <0.001 |
Gender  Males | 35 (35.4) |  |  |
     Females | 40 (33.9) | 0.94 (0.54; 1.64) | 0.822 |
WAZ  ≥−2 | 36 (55) |  |  |
     <−2 | 39 (40) | 1.57(0.86; 2.87) | 0.116 |
Diastolic Blood Pressure | Â | Â | Â |
     Normal | 61(32.3) |  |  |
     Low | 5 (45.5) | 1.75 (0.51; 5.95) | 0.371 |
     High | 8 (57.1) | 2.80 (0.93; 8.42) | 0.067 |
Clinical stages | Â | Â | Â |
     Stage 1-3 | 58 (31.2) |  |  |
     Stage 4 | 17 (54.8) | 2.68 (1.24; 5.80) | 0.012 |
Immunological stage | Â | Â | Â |
     Not significant | 29 (36.3) |  |  |
     Mild | 12 (35.3) | 0.96 (0.42; 2.22) | 0.922 |
     Advanced | 7 (20.0) | 0.44 (0.17; 1.13) | 0.088 |
     Severe | 20 (43.5) | 1.35 (0.65; 2.84) | 0.424 |